Tang Capital Management LLC Raises Holdings in Pyxis Oncology, Inc. (NASDAQ:PYXS)

Tang Capital Management LLC grew its position in Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Rating) by 145.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,470,700 shares of the company’s stock after buying an additional 2,059,131 shares during […]

Related Keywords

William Blair , Tang Capital Management , Vanguard Group Inc , Citadel Advisors , Tower Research Capital , Pyxis Oncology Inc , Credit Suisse Group , Pyxis Oncology Company Profile , Blackrock Inc , Securities Exchange Commission , Nasdaq , Pfizer Inc , Goldman Sachs Group Inc , Pyxis Oncology , Get Rating , Capital Management , Research Capital , Goldman Sachs Group , Exchange Commission , Suisse Group , Lifesci Capital , Pyxis Oncology Daily ,